Clinical Trials Browser

Withdrawn × INDUSTRY × Epirubicin × Clear all

NCT06829199 2026-02-19

MK-5890-003

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01205217 2017-06-07

ELATE

Phase 2 Withdrawn

Breast Neoplasms